NO180475C - Fremgangsmåte for fremstilling av et farmasöytisk preparat - Google Patents

Fremgangsmåte for fremstilling av et farmasöytisk preparat

Info

Publication number
NO180475C
NO180475C NO905106A NO905106A NO180475C NO 180475 C NO180475 C NO 180475C NO 905106 A NO905106 A NO 905106A NO 905106 A NO905106 A NO 905106A NO 180475 C NO180475 C NO 180475C
Authority
NO
Norway
Prior art keywords
weight
denotes
preparation
pharmaceutical composition
polyloxyethylene
Prior art date
Application number
NO905106A
Other languages
English (en)
Norwegian (no)
Other versions
NO905106L (no
NO180475B (no
NO905106D0 (no
Inventor
Walter F Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of NO905106D0 publication Critical patent/NO905106D0/no
Publication of NO905106L publication Critical patent/NO905106L/no
Publication of NO180475B publication Critical patent/NO180475B/no
Publication of NO180475C publication Critical patent/NO180475C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO905106A 1989-11-29 1990-11-26 Fremgangsmåte for fremstilling av et farmasöytisk preparat NO180475C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (4)

Publication Number Publication Date
NO905106D0 NO905106D0 (no) 1990-11-26
NO905106L NO905106L (no) 1991-05-30
NO180475B NO180475B (no) 1997-01-20
NO180475C true NO180475C (no) 1997-04-30

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
NO905106A NO180475C (no) 1989-11-29 1990-11-26 Fremgangsmåte for fremstilling av et farmasöytisk preparat

Country Status (29)

Country Link
US (1) US5118698A (es)
EP (1) EP0430149B1 (es)
JP (1) JPH0660097B2 (es)
KR (1) KR940000066B1 (es)
CN (1) CN1035357C (es)
AT (1) ATE102051T1 (es)
AU (1) AU626480B2 (es)
BR (1) BR9006025A (es)
CA (1) CA2030911C (es)
CY (1) CY1970A (es)
CZ (1) CZ282898B6 (es)
DE (2) DE3939492A1 (es)
DK (1) DK0430149T3 (es)
EG (1) EG19557A (es)
ES (1) ES2062271T3 (es)
FI (1) FI103713B1 (es)
HK (1) HK216896A (es)
HU (1) HU220867B1 (es)
IE (1) IE64672B1 (es)
IL (1) IL96450A (es)
MX (1) MX23518A (es)
MY (1) MY104540A (es)
NO (1) NO180475C (es)
NZ (1) NZ236255A (es)
PT (1) PT96003B (es)
RU (1) RU2038080C1 (es)
SK (1) SK595390A3 (es)
YU (1) YU227290A (es)
ZA (1) ZA909549B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7880991A (en) * 1990-05-10 1991-11-27 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
BR0207698A (pt) * 2001-02-28 2004-04-20 Akzo Nobel Nv Adjuvante para uso em formulação de vacina, vacina, e, uso de um emulsificante polimérico
PT1471887E (pt) 2002-02-04 2010-07-16 Elan Pharma Int Ltd ComposiãŽes de nanopartculas com lisozima como um estabilizador superficial
CA2492488A1 (en) * 2002-07-16 2004-01-22 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (es) * 1982-06-09 1984-10-22 Pfizer
ZA858001B (en) * 1984-10-19 1986-05-28 Schering Corp 1,3-bis(1h-1,2,4-triazol-1-yl)-2-fluoro-2(2,4-difluorophenyl)propane,antifungal composition containing it,and process for preparation of the compound and the composition

Also Published As

Publication number Publication date
MX23518A (es) 1993-04-01
US5118698A (en) 1992-06-02
IL96450A (en) 1994-10-21
KR910009286A (ko) 1991-06-28
AU6706590A (en) 1991-08-08
IE904282A1 (en) 1991-06-05
CZ595390A3 (en) 1997-06-11
HUT57039A (en) 1991-11-28
CZ282898B6 (cs) 1997-11-12
CA2030911A1 (en) 1991-05-30
FI905814A0 (fi) 1990-11-26
JPH0660097B2 (ja) 1994-08-10
SK280599B6 (sk) 2000-04-10
MY104540A (en) 1994-04-30
NZ236255A (en) 1992-02-25
SK595390A3 (en) 2000-04-10
FI103713B (fi) 1999-08-31
NO905106L (no) 1991-05-30
EG19557A (en) 1997-08-31
EP0430149B1 (en) 1994-03-02
HU220867B1 (en) 2002-06-29
IE64672B1 (en) 1995-08-23
KR940000066B1 (ko) 1994-01-05
CA2030911C (en) 1995-02-07
NO180475B (no) 1997-01-20
PT96003A (pt) 1991-09-13
DK0430149T3 (da) 1994-03-28
NO905106D0 (no) 1990-11-26
DE69007029T2 (de) 1994-06-09
JPH03176421A (ja) 1991-07-31
YU227290A (sh) 1993-10-20
ZA909549B (en) 1992-06-24
ES2062271T3 (es) 1994-12-16
RU2038080C1 (ru) 1995-06-27
DE3939492A1 (de) 1991-06-06
BR9006025A (pt) 1991-09-24
FI905814A (fi) 1991-05-30
AU626480B2 (en) 1992-07-30
DE69007029D1 (de) 1994-04-07
FI103713B1 (fi) 1999-08-31
ATE102051T1 (de) 1994-03-15
EP0430149A2 (en) 1991-06-05
EP0430149A3 (en) 1991-09-25
HK216896A (en) 1996-12-27
CN1052046A (zh) 1991-06-12
PT96003B (pt) 1998-01-30
CN1035357C (zh) 1997-07-09
CY1970A (en) 1997-09-05

Similar Documents

Publication Publication Date Title
NO813359L (no) Fremgangsmaate for fremstilling av 1,2,3,4-tetrahydro-isokinolin-3-karboksylsyre-derivater
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FI820281L (fi) Foerfarande foer framstaellning av 2-penemkompositioner med forfarandet framstaellda nya 2-penemkompositioner och dessa inehaollande farmaceutiska blandningar
ATE89263T1 (de) Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE109770T1 (de) Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten.
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
NO180475C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat
FI104071B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 2,5-dihydro-2,5-diokso-1H-bents£b|atsepiinijohdannaisten valmistamiseksi
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
SE8505369L (sv) Nya tienopyridinderivat, ett forfarande for framstellning derav och terapeutiska kompositioner innehallande dem
NO166713C (no) Analogifremgangsmaate for fremstikling av terapeutisk aktive monobasiske diisobutamid derivater.
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem
ATE36154T1 (de) 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
SE9402596L (sv) Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa föreningar
SE8100122L (sv) Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa
RU92016560A (ru) Замещенные бензоимидазолы, фармацевтическая композиция, способ ингибирования или лечения и способ их получения и применение